Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists


Phase N/A Results N/A

Summary of Purpose

The aim of this study is to assess the real world comparative effectiveness of Rivaroxaban prescribed in non-valvular atrial fibrillation (NVAF) routine care patients in Germany.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 December 2017.

15 Oct 2016 12 Oct 2016 31 Dec 2016 31 Dec 2016 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available


Not available